10岁以下儿童芬太尼暴露的特征分析
该研究为单中心儿童医院回顾性病历审查,纳入25例经尿液芬太尼免疫分析或确证性尿液药物检测证实芬太尼暴露的10岁以下儿童。中位年龄14个月,多数有症状:中枢神经抑制92%、呼吸抑制88%、瞳孔缩小73%;8例(31%)需心肺复苏。22例(85%)住院,其中ICU 16例(62%)、普通病房6例(23%);23例(92%)需至少一剂纳洛酮,其中10例院前给药、14例需多剂、10例需输注,末次纳洛酮给药中位时间219分钟(IQR 2-429分钟)。芬太尼免疫分析实时检出超过半数患者,作者强调早期识别以便及时干预、安全评估和出院时开具纳洛酮。
要点
- 25例10岁以下芬太尼暴露儿童中,中枢神经抑制92%、呼吸抑制88%、瞳孔缩小73%,8例(31%)需心肺复苏。
- 23例(92%)需至少一剂纳洛酮,其中14例需多剂、10例需输注,末次纳洛酮给药中位时间219分钟(IQR 2-429分钟)。
- 22例(85%)住院,ICU 16例(62%)、普通病房6例(23%);5例(19%)出院时开具纳洛酮。
- 芬太尼免疫分析在实时检测中检出超过半数患者,作者强调该检测的重要性。
- 作者认为早期识别芬太尼毒性有助于及时干预、安全评估和出院时开具纳洛酮。
适用人群与场景
- 单中心儿童医院中10岁以下、经尿液芬太尼免疫分析或确证性尿液药物检测证实芬太尼暴露的患儿。
诊断标准与关键阈值
- 芬太尼暴露确诊标准:尿液芬太尼免疫分析或确证性尿液药物检测阳性。
处置流程与药物剂量
- 23例(92%)接受至少一剂纳洛酮,其中10例为院前给药、14例需多剂、10例需纳洛酮输注;末次纳洛酮给药中位时间219分钟(IQR 2-429分钟)。
- 纳洛酮反应表现为呼吸频率改善(100%)或意识状态改善(100%)。
- 5例(19%)出院时开具纳洛酮。
红旗征与不能漏的情况
- 中枢神经抑制(92%)、呼吸抑制(88%)、瞳孔缩小(73%);8例(31%)需心肺复苏。
研究设计与关键结果
- 回顾性病历审查,单中心儿童医院,25例10岁以下证实芬太尼暴露患儿,中位年龄14个月。
- 主要表现:中枢神经抑制92%、呼吸抑制88%、瞳孔缩小73%;8例(31%)需心肺复苏。
- 22例(85%)住院,其中ICU 16例(62%)、普通病房6例(23%);23例(92%)需至少一剂纳洛酮,10例院前给药、14例需多剂、10例需输注;5例(19%)出院带纳洛酮。
- 芬太尼免疫分析在实时检测中检出超过半数患者。
证据类型、等级与局限
- 证据类型:单中心回顾性病历审查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为早期识别芬太尼毒性有助于及时干预、安全评估和出院时开具纳洛酮。
- 芬太尼免疫分析在实时检测中检出超过半数患者,作者强调该检测的重要性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Illicitly manufactured fentanyl has become increasingly relevant to pediatric populations. However, there are limited studies examining clinical course and treatment of fentanyl exposures in children to guide management. The objective of this study was to describe clinical characteristics, management, and outcomes in fentanyl exposures in children less than 10 years old.
METHODS: This was a retrospective chart review at a single children's hospital including patients less than 10 years old with a confirmed fentanyl exposure, as defined by urine fentanyl immunoassay or confirmatory urine drug test. Further chart review was performed to obtain demographics, source of exposure, symptoms, treatment, disposition, and outcomes.
RESULTS: Twenty-five subjects met inclusion criteria. Median age was 14 months. The majority of patients were symptomatic with central nervous system depression (92%), respiratory depression (88%), and miosis (73%). Eight patients (31%) required cardiopulmonary resuscitation. Most encounters resulted in admission (n = 22, 85%) with six patients (23%) admitted to the floor and 16 patients (62%) admitted to the intensive care unit. Twenty-three patients (92%) required at least one dose of naloxone. Of those, 10 patients received prehospital naloxone, 14 required multiple doses, and 10 received an infusion. The median time to last dose of naloxone was 219 min (IQR: 2-429 min). Response to naloxone was evidenced by improvement in respiratory rate (100%) or mental status (100%). Five patients (19%) were discharged with naloxone.
DISCUSSION: We highlight the impact fentanyl exposures have on the young pediatric population, with the majority of patients demonstrating central nervous system and respiratory depression, several requiring cardiopulmonary resuscitation, and almost all necessitating naloxone therapy and hospital admission. Fentanyl immunoassays detected over half of patients in real time, underscoring the importance of this assay.
CONCLUSION: Young patients are at risk for severe clinical symptoms following fentanyl exposure. Early recognition of fentanyl toxicity allows for timely intervention, safety assessments, and naloxone prescription upon discharge.
参考来源
- Massengill D, Rosenberg L, Forst E, et al. Characterization of fentanyl exposures in children less than 10 years old. Clin Toxicol (Phila). 2026. PMID: 41711428. doi:10.1080/15563650.2026.2625871
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。